Development of New Intestinal Organ-on-Chip Platforms for Drug Development Research
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Altis Biosystems, Inc.
Award Date
Award Amount
500,000
Program Name
Strategic Growth Loan
Program Category
Business Financing
Principal Investigator
Michael Biron
Fiscal Year
2022
Region
Research Triangle
Project Description:
Altis Biosystems is developing novel “intestine-on-chip†technology for use in drug discovery research. The company was awarded $500,000 in SGL funding to support the development and commercialization of two new expanded capability platforms, RepliGut® LTC and RepliGut® 2D Crypt, that will better support drug discovery for chronic intestinal conditions such as Crohn's Disease.